Boots Middle East launches No7’S most anticipated beauty range in the UAE

Boots Middle East launches No7’S most anticipated beauty range in the UAE

No7’s new super peptide is set to be one of the most effective and tolerated skincare ingredients on the cosmetic market. Unlike retinoic acid, which is known by dermatologists to cause tolerance challenges such as skin sensitivity and redness, No7's new super peptide is both highly potent and highly tolerated, being suitable even for those with sensitive skin. This paves the way to highly effective skincare being available to even more people.

At the heart of the collection is the No7 Future Renew Repair Serum, clinically proven in a blinded split-face controlled trial to reverse the appearance of multiple signs of skin damage across a range of skin types and tones, including fine lines, wrinkles, lack of luminosity, dryness, uneven skin tone and loss of firmness. 97% of women in the clinical study had improvements in the appearance of multiple (3 or more) visible signs of skin damage. Patent applications have been submitted and are pending for both the new peptides and the delivery system found within the serum.

The new super peptide technology has been met with excitement from the global scientific community with the technology being presented at three world-leading scientific conferences this Spring including the American Academy of Dermatology